info@marketresearchfuture.com   đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Hyaluronic Acid Market Research Report Information By Grade (Cosmetic Grade, Pharmaceutical Grade, Food Grade), By Application (Aesthetics, Osteoarthritis, Pharmaceutical API, Cosmetics, Dietary Supplements, Ophthalmology, Others), By End Users (Pharmaceutical Industry, Dermatology Clinics, Cosmetic Surgery Centers, Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Forecast Till 2032


ID: MRFR/HC/5965-CR | 161 Pages | Author: Kinjoll Dey| August 2021

Market Segmentation Tab OF Hyaluronic Acid Market


Hyaluronic Acid Grade Outlook (USD Billion, 2018-2030)



  • Cosmetic Grade

  • Pharmaceutical Grade

  • Food Grade


Hyaluronic Acid Application Outlook (USD Billion, 2018-2030)



  • Aesthetics

  • Osteoarthritis

  • Pharmaceutical API

  • Cosmetics

  • Dietary Supplements

  • Ophthalmology

  • Others


Hyaluronic Acid End User Outlook (USD Billion, 2018-2030)



  • Pharmaceutical Industry

  • Dermatology Clinics

  • Cosmetic Surgery Centers

  • Others


Hyaluronic Acid Regional Outlook (USD Billion, 2018-2030)




  • North America Outlook (USD Billion, 2018-2030)


    • North America Hyaluronic Acid by Grade

      • Cosmetic Grade

      • Pharmaceutical Grade

      • Food Grade




    • North America Hyaluronic Acid by Application

      • Aesthetics

      • Osteoarthritis

      • Pharmaceutical API

      • Cosmetics

      • Dietary Supplements

      • Ophthalmology

      • Others




    • North America Hyaluronic Acid by End User

      • Pharmaceutical Industry

      • Dermatology Clinics

      • Cosmetic Surgery Centers

      • Others



    • US Outlook (USD Billion, 2018-2030)


    • US Hyaluronic Acid by Grade

      • Cosmetic Grade

      • Pharmaceutical Grade

      • Food Grade




    • US Hyaluronic Acid by Application

      • Aesthetics

      • Osteoarthritis

      • Pharmaceutical API

      • Cosmetics

      • Dietary Supplements

      • Ophthalmology

      • Others




    • US Hyaluronic Acid by End User

      • Pharmaceutical Industry

      • Dermatology Clinics

      • Cosmetic Surgery Centers

      • Others



    • Canada Outlook (USD Billion, 2018-2030)


    • Canada Hyaluronic Acid by Grade

      • Cosmetic Grade

      • Pharmaceutical Grade

      • Food Grade




    • Canada Hyaluronic Acid by Application

      • Aesthetics

      • Osteoarthritis

      • Pharmaceutical API

      • Cosmetics

      • Dietary Supplements

      • Ophthalmology

      • Others




    • Canada Hyaluronic Acid by End User

      • Pharmaceutical Industry

      • Dermatology Clinics

      • Cosmetic Surgery Centers

      • Others




    • Europe Outlook (USD Billion, 2018-2030)


      • Europe Hyaluronic Acid by Grade

        • Cosmetic Grade

        • Pharmaceutical Grade

        • Food Grade




      • Europe Hyaluronic Acid by Application

        • Aesthetics

        • Osteoarthritis

        • Pharmaceutical API

        • Cosmetics

        • Dietary Supplements

        • Ophthalmology

        • Others




      • Europe Hyaluronic Acid by End User

        • Pharmaceutical Industry

        • Dermatology Clinics

        • Cosmetic Surgery Centers

        • Others




      • Germany Outlook (USD Billion, 2018-2030)


      • Germany Hyaluronic Acid by Grade

        • Cosmetic Grade

        • Pharmaceutical Grade

        • Food Grade




      • Germany Hyaluronic Acid by Application

        • Aesthetics

        • Osteoarthritis

        • Pharmaceutical API

        • Cosmetics

        • Dietary Supplements

        • Ophthalmology

        • Others




      • Germany Hyaluronic Acid by End User

        • Pharmaceutical Industry

        • Dermatology Clinics

        • Cosmetic Surgery Centers

        • Others



      • France Outlook (USD Billion, 2018-2030)


      • France Hyaluronic Acid by Grade

        • Cosmetic Grade

        • Pharmaceutical Grade

        • Food Grade




      • France Hyaluronic Acid by Application

        • Aesthetics

        • Osteoarthritis

        • Pharmaceutical API

        • Cosmetics

        • Dietary Supplements

        • Ophthalmology

        • Others




      • France Hyaluronic Acid by End User

        • Pharmaceutical Industry

        • Dermatology Clinics

        • Cosmetic Surgery Centers

        • Others



      • UK Outlook (USD Billion, 2018-2030)


      • UK Hyaluronic Acid by Grade

        • Cosmetic Grade

        • Pharmaceutical Grade

        • Food Grade




      • UK Hyaluronic Acid by Application

        • Aesthetics

        • Osteoarthritis

        • Pharmaceutical API

        • Cosmetics

        • Dietary Supplements

        • Ophthalmology

        • Others




      • UK Hyaluronic Acid by End User

        • Pharmaceutical Industry

        • Dermatology Clinics

        • Cosmetic Surgery Centers

        • Others




      • Italy Outlook (USD Billion, 2018-2030)


      • Italy Hyaluronic Acid by Grade

        • Cosmetic Grade

        • Pharmaceutical Grade

        • Food Grade




      • Italy Hyaluronic Acid by Application

        • Aesthetics

        • Osteoarthritis

        • Pharmaceutical API

        • Cosmetics

        • Dietary Supplements

        • Ophthalmology

        • Others




      • Italy Hyaluronic Acid by End User

        • Pharmaceutical Industry

        • Dermatology Clinics

        • Cosmetic Surgery Centers

        • Others



      • Spain Outlook (USD Billion, 2018-2030)


      • Spain Hyaluronic Acid by Grade

        • Cosmetic Grade

        • Pharmaceutical Grade

        • Food Grade




      • Spain Hyaluronic Acid by Application

        • Aesthetics

        • Osteoarthritis

        • Pharmaceutical API

        • Cosmetics

        • Dietary Supplements

        • Ophthalmology

        • Others




      • Spain Hyaluronic Acid by End User

        • Pharmaceutical Industry

        • Dermatology Clinics

        • Cosmetic Surgery Centers

        • Others



      • Rest Of Europe Outlook (USD Billion, 2018-2030)


      • Rest Of Europe Hyaluronic Acid by Grade

        • Cosmetic Grade

        • Pharmaceutical Grade

        • Food Grade




      • Rest of Europe Hyaluronic Acid by Application

        • Aesthetics

        • Osteoarthritis

        • Pharmaceutical API

        • Cosmetics

        • Dietary Supplements

        • Ophthalmology

        • Others




      • Rest of Europe Hyaluronic Acid by End User

        • Pharmaceutical Industry

        • Dermatology Clinics

        • Cosmetic Surgery Centers

        • Others




      • Asia-Pacific Outlook (USD Billion, 2018-2030)


        • Asia-Pacific Hyaluronic Acid by Grade

          • Cosmetic Grade

          • Pharmaceutical Grade

          • Food Grade




        • Asia-Pacific Hyaluronic Acid by Application

          • Aesthetics

          • Osteoarthritis

          • Pharmaceutical API

          • Cosmetics

          • Dietary Supplements

          • Ophthalmology

          • Others




        • Asia-Pacific Hyaluronic Acid by End User

          • Pharmaceutical Industry

          • Dermatology Clinics

          • Cosmetic Surgery Centers

          • Others



        • China Outlook (USD Billion, 2018-2030)


        • China Hyaluronic Acid by Grade

          • Cosmetic Grade

          • Pharmaceutical Grade

          • Food Grade




        • China Hyaluronic Acid by Application

          • Aesthetics

          • Osteoarthritis

          • Pharmaceutical API

          • Cosmetics

          • Dietary Supplements

          • Ophthalmology

          • Others




        • China Hyaluronic Acid by End User

          • Pharmaceutical Industry

          • Dermatology Clinics

          • Cosmetic Surgery Centers

          • Others



        • Japan Outlook (USD Billion, 2018-2030)


        • Japan Hyaluronic Acid by Grade

          • Cosmetic Grade

          • Pharmaceutical Grade

          • Food Grade




        • Japan Hyaluronic Acid by Application

          • Aesthetics

          • Osteoarthritis

          • Pharmaceutical API

          • Cosmetics

          • Dietary Supplements

          • Ophthalmology

          • Others




        • Japan Hyaluronic Acid by End User

          • Pharmaceutical Industry

          • Dermatology Clinics

          • Cosmetic Surgery Centers

          • Others



        • India Outlook (USD Billion, 2018-2030)


        • India Hyaluronic Acid by Grade

          • Cosmetic Grade

          • Pharmaceutical Grade

          • Food Grade




        • India Hyaluronic Acid by Application

          • Aesthetics

          • Osteoarthritis

          • Pharmaceutical API

          • Cosmetics

          • Dietary Supplements

          • Ophthalmology

          • Others




        • India Hyaluronic Acid by End User

          • Pharmaceutical Industry

          • Dermatology Clinics

          • Cosmetic Surgery Centers

          • Others



        • Australia Outlook (USD Billion, 2018-2030)


        • Australia Hyaluronic Acid by Grade

          • Cosmetic Grade

          • Pharmaceutical Grade

          • Food Grade




        • Australia Hyaluronic Acid by Application

          • Aesthetics

          • Osteoarthritis

          • Pharmaceutical API

          • Cosmetics

          • Dietary Supplements

          • Ophthalmology

          • Others




        • Australia Hyaluronic Acid by End User

          • Pharmaceutical Industry

          • Dermatology Clinics

          • Cosmetic Surgery Centers

          • Others



        • South Korea Outlook (USD Billion, 2018-2030)


        • South Korea Hyaluronic Acid by Grade

          • Cosmetic Grade

          • Pharmaceutical Grade

          • Food Grade




        • South Korea Hyaluronic Acid by Application

          • Aesthetics

          • Osteoarthritis

          • Pharmaceutical API

          • Cosmetics

          • Dietary Supplements

          • Ophthalmology

          • Others




        • South Korea Hyaluronic Acid by End User

          • Pharmaceutical Industry

          • Dermatology Clinics

          • Cosmetic Surgery Centers

          • Others




        • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)


        • Rest of Asia-Pacific Hyaluronic Acid by Grade

          • Cosmetic Grade

          • Pharmaceutical Grade

          • Food Grade




        • Rest of Asia-Pacific Hyaluronic Acid by Application

          • Aesthetics

          • Osteoarthritis

          • Pharmaceutical API

          • Cosmetics

          • Dietary Supplements

          • Ophthalmology

          • Others




        • Rest of Asia-Pacific Hyaluronic Acid by End User

          • Pharmaceutical Industry

          • Dermatology Clinics

          • Cosmetic Surgery Centers

          • Others




        • Rest of the World Outlook (USD Billion, 2018-2030)


          • Rest of the World Hyaluronic Acid by Grade

            • Cosmetic Grade

            • Pharmaceutical Grade

            • Food Grade




          • Rest of the World Hyaluronic Acid by Application

            • Aesthetics

            • Osteoarthritis

            • Pharmaceutical API

            • Cosmetics

            • Dietary Supplements

            • Ophthalmology

            • Others




          • Rest of the World Hyaluronic Acid by End User

            • Pharmaceutical Industry

            • Dermatology Clinics

            • Cosmetic Surgery Centers

            • Others



          • Middle East Outlook (USD Billion, 2018-2030)


          • Middle East Hyaluronic Acid by Grade

            • Cosmetic Grade

            • Pharmaceutical Grade

            • Food Grade




          • Middle East Hyaluronic Acid by Application

            • Aesthetics

            • Osteoarthritis

            • Pharmaceutical API

            • Cosmetics

            • Dietary Supplements

            • Ophthalmology

            • Others




          • Middle East Hyaluronic Acid by End User

            • Pharmaceutical Industry

            • Dermatology Clinics

            • Cosmetic Surgery Centers

            • Others



          • Africa Outlook (USD Billion, 2018-2030)


          • Africa Hyaluronic Acid by Grade

            • Cosmetic Grade

            • Pharmaceutical Grade

            • Food Grade




          • Africa Hyaluronic Acid by Application

            • Aesthetics

            • Osteoarthritis

            • Pharmaceutical API

            • Cosmetics

            • Dietary Supplements

            • Ophthalmology

            • Others




          • Africa Hyaluronic Acid by End User

            • Pharmaceutical Industry

            • Dermatology Clinics

            • Cosmetic Surgery Centers

            • Others



          • Latin America Outlook (USD Billion, 2018-2030)


          • Latin America Hyaluronic Acid by Grade

            • Cosmetic Grade

            • Pharmaceutical Grade

            • Food Grade




          • Latin America Hyaluronic Acid by Application

            • Aesthetics

            • Osteoarthritis

            • Pharmaceutical API

            • Cosmetics

            • Dietary Supplements

            • Ophthalmology

            • Others




          • Latin America Hyaluronic Acid by End User

            • Pharmaceutical Industry

            • Dermatology Clinics

            • Cosmetic Surgery Centers

            • Others











Research Methodology on Hyaluronic Acid Market


1 Introduction


The research report, “Hyaluronic Acid Market”, provides an in-depth analysis of the market landscape and its various aspects. It provides an exhaustive analysis of the market by segmenting it based on type, source, form, application, and region, the analysis provides forecasts of the market’s development during the forecast period (2023-2030). This report is based on the data collated from our primary and secondary sources and offers stakeholders and readers an insight into the strategic development initiatives that the vendors are focusing on.


The objective of the research study is to analyze and forecast the market size of the global hyaluronic acid market and the market growth rate of the forecast period.


2 Research Methodology


The research methodology used for the research and analysis of the data for the report consists of a combination of primary and secondary research and triangulation of the research obtained from multiple sources.


The primary research includes in-depth interviews with key executives from the industry and an in-house panel expert from our research team provided an overall validation of the data obtained through the process. An exhaustive analysis of each week is carried out to understand the developments within the industry and the overall environment.


The secondary research is conducted by utilizing different sources such as search engines like Google, Yahoo, Bing, etc., and by accessing government data such as statistical figures, press releases and publications from the Ministry of Commerce and Industry, the World Bank and World Health Organization, etc.


The qualitative data obtained from the secondary sources are compared to the qualitative data obtained from our primary sources. The triangulation of the data obtained from our primary and secondary sources enables us to arrive at an industry average that was used for our analysis.


3 Data Sources


The primary sources of information include our industry experts, industry associations and trade associations, government websites and publications, directories, and secondary bench-marking, the sources to gather quantitative data for this report include:


a) Primary sources:



  • Expert panel interviews

  • In-depth interviews with industry leaders


b) Secondary sources:



  • Company websites

  • Government websites and publications

  • News Reports, Publications, and Government Databases

  • Company News and Reports

  • Financial Reports

  • Conferences & exhibitions

  • Patents & trade literature


4 Research and Analysis Division


The research and analysis division of the report focuses on three major categories, namely market overview, market analysis and forecast, and competitive landscape.


The market overview provides an overview of the market and its industry development, market size, and various key developments and trends.


The market analysis and forecast section covers an in-depth analysis of the industry and its particular segments, by volume and value (USD), and a forecast of the market development during the forecast period.


The competitive landscape section covers the strategies of the key players, their financial performance, and more.


5 Assumptions


The research assumptions include:



  • The market size is determined based on the product type, region, and application.

  • The competitive landscape is determined based on the top 10 vendors in the market and their competitive strategies.

  • The global market numbers are estimated using the bottom-up approach.

  • The information collected from primary sources is validated by secondary sources including company websites and other publications.

  • The price structure is estimated based on the product price and its sales volume.


Due to the above assumptions mentioned, there may be considerable differences between the actual results and the estimates provided in the report.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Content

LIST OF CONTENTS

1 EXECUTIVE SUMMARY 16

2 MARKET INTRODUCTION 18

2.1 SCOPE OF THE STUDY 18

2.2 RESEARCH OBJECTIVE 18

2.3 MARKET STRUCTURE 18

2.4 ASSUMPTIONS & LIMITATIONS 19

3 RESEARCH METHODOLOGY 20

3.1 DATA MINING 20

3.2 SECONDARY RESEARCH 21

3.3 PRIMARY RESEARCH 22

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 23

3.5 FORECASTING TECHNIQUES 24

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25

3.6.1 BOTTOM-UP APPROACH 26

3.6.2 TOP-DOWN APPROACH 26

3.7 DATA TRIANGULATION 27

3.8 VALIDATION 27

4 MARKET DYNAMICS 28

4.1 INTRODUCTION 28

4.2 DRIVERS 29

4.2.1 INCREASING APPLICATION OF HYALURONIC ACID IN COSMETIC & PERSONAL CARE PRODUCTS 29

4.2.2 INCREASING NUMBER OF COSMETIC SURGERIES 31

4.2.3 EXTENSIVE USE OF HYALURONIC ACID IN THE TREATMENT OF OSTEOARTHRITIS AND DRY EYE 32

4.3 RESTRAINTS 33

4.3.1 AVAILABILITY OF SUBSTITUTES 33

4.4 OPPORTUNITY 34

4.4.1 EXTENSIVE R&D ASSOCIATED WITH HYALURONIC ACID 34

4.5 TREND 35

4.5.1 USE OF HYALURONIC ACID AS AN ANIMAL SUPPLEMENT 35

5 MARKET FACTOR ANALYSIS 36

5.1 SUPPLY CHAIN ANALYSIS 36

5.1.1 RAW MATERIAL SUPPLIERS 37

5.1.2 HYALURONIC ACID PRODUCERS 37

5.1.3 DISTRIBUTION & SALES CHANNEL 37

5.1.4 END USERS 38

5.2 PORTER’S FIVE FORCES MODEL 38

5.2.1 BARGAINING POWER OF SUPPLIERS 39

5.2.2 BARGAINING POWER OF BUYERS 39

5.2.3 THREAT OF NEW ENTRANTS 39

5.2.4 THREAT OF SUBSTITUTES 39

5.2.5 INTENSITY OF RIVALRY 39

5.3 COVID-19 IMPACT ANALYSIS 40

5.3.1 IMPACT ON GROWTH RATE 40

5.3.2 IMPACT ON MAJOR PLAYERS 40

5.3.3 IMPACT ON PREFERENCE OF CUSTOMERS 40

5.3.4 IMPACT ON AESTHETIC INDUSTRY 42

6 GLOBAL HYALURONIC ACID MARKET, BY GRADE 43

6.1 OVERVIEW 43

6.2 COSMETIC GRADE 45

6.3 PHARMACEUTICAL GRADE 46

6.4 FOOD GRADE 47

7 GLOBAL HYALURONIC ACID MARKET, BY APPLICATION 48

7.1 OVERVIEW 48

7.2 AESTHETICS 49

7.3 OSTEOARTHRITIS 50

7.4 PHARMACEUTICAL API 51

7.5 COSMETICS 52

7.6 DIETARY SUPPLEMENTS 53

7.7 OPHTHALMOLOGY 54

7.8 OTHERS 54

8 GLOBAL HYALURONIC ACID MARKET, BY END USER 56

8.1 OVERVIEW 56

8.2 PHARMACEUTICAL INDUSTRY 58

8.3 DERMATOLOGY CLINICS & COSMETIC SURGERY CENTERS 59

8.4 FOOD INDUSTRY 60

8.5 PERSONAL CARE 61

8.6 OTHERS 61

9 GLOBAL HYALURONIC ACID MARKET, BY REGION 63

9.1 OVERVIEW 63

9.2 NORTH AMERICA 65

9.2.1 US 67

9.2.2 CANADA 69

9.3 EUROPE 71

9.3.1 FRANCE 74

9.3.2 GERMANY 75

9.3.3 UK 77

9.3.4 SPAIN 78

9.3.5 ITALY 80

9.3.6 RUSSIA 81

9.3.7 BELGIUM 83

9.3.8 POLAND 84

9.3.9 REST OF EUROPE 86

9.4 ASIA-PACIFIC 88

9.4.1 CHINA 91

9.4.2 JAPAN 92

9.4.3 INDIA 94

9.4.4 SOUTH KOREA 95

9.4.5 AUSTRALIA 97

9.4.6 THAILAND 98

9.4.7 INDONESIA 100

9.4.8 REST OF ASIA-PACIFIC 101

9.5 LATIN AMERICA 103

9.5.1 BRAZIL 105

9.5.2 MEXICO 107

9.5.3 ARGENTINA 108

9.5.4 REST OF LATIN AMERICA 110

9.6 MIDDLE EAST & AFRICA 112

9.6.1 SAUDI ARABIA 115

9.6.2 UAE 116

9.6.3 TURKEY 118

9.6.4 SOUTH AFRICA 119

9.6.5 ISRAEL 121

9.6.6 REST OF THE MIDDLE EAST &AFRICA 122

10 COMPETITIVE LANDSCAPE 124

10.1 OVERVIEW 124

10.2 COMPETITIVE BENCHMARKING 125

10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL HYALURONIC ACID MARKET 127

10.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 128

10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 129

10.5.1 JOINT VENTURES & AGREEMENTS 130

10.5.2 MARKETING STRATEGY 130

10.5.3 MERGERS&ACQUISITIONS 130

10.6 FINANCIAL MATRIX 131

11 COMPANY PROFILES 132

11.1 ALLERGAN PLC 132

11.1.1 COMPANY OVERVIEW 132

11.1.2 FINANCIAL OVERVIEW 133

11.1.3 PRODUCTS/SERVICES OFFERED 133

11.1.4 KEY DEVELOPMENTS 134

11.1.5 SWOT ANALYSIS 134

11.1.6 KEY STRATEGIES 135

11.2 CONTIPRO AS. 136

11.2.1 COMPANY OVERVIEW 136

11.2.2 FINANCIAL OVERVIEW 136

11.2.3 PRODUCTS OFFERED 136

11.2.4 KEY DEVELOPMENTS 137

11.2.5 SWOT ANALYSIS 137

11.2.6 KEY STRATEGIES 137

11.3 SYMATESE 138

11.3.1 COMPANY OVERVIEW 138

11.3.2 FINANCIAL OVERVIEW 138

11.3.3 PRODUCTS OFFERED 138

11.3.4 KEY DEVELOPMENTS 138

11.3.5 SWOT ANALYSIS 139

11.3.6 KEY STRATEGIES 139

11.4 ZHONGLAN INDUSTRY CO., LTD. 140

11.4.1 COMPANY OVERVIEW 140

11.4.2 FINANCIAL OVERVIEW 140

11.4.3 PRODUCTS OFFERED 140

11.4.4 KEY DEVELOPMENTS 140

11.4.5 SWOT ANALYSIS 141

11.4.6 KEY STRATEGIES 141

11.5 ALTERGON ITALIA SRL 142

11.5.1 COMPANY OVERVIEW 142

11.5.2 FINANCIAL OVERVIEW 142

11.5.3 PRODUCTS OFFERED 142

11.5.4 KEY DEVELOPMENTS 142

11.5.5 SWOT ANALYSIS 143

11.5.6 KEY STRATEGIES 143

11.6 FIDIA FARMACEUTICI S.P.A. 144

11.6.1 COMPANY OVERVIEW 144

11.6.2 FINANCIAL OVERVIEW 144

11.6.3 PRODUCTS OFFERED 144

11.6.4 KEY DEVELOPMENTS 144

11.6.5 SWOT ANALYSIS 145

11.6.6 KEY STRATEGIES 145

11.7 BIOIBERICA SAU. 146

11.7.1 COMPANY OVERVIEW 146

11.7.2 FINANCIAL OVERVIEW 146

11.7.3 PRODUCTS OFFERED 146

11.7.4 KEY DEVELOPMENTS 146

11.7.5 SWOT ANALYSIS 147

11.7.6 KEY STRATEGIES 147

11.8 KEWPIE CORPORATION 148

11.8.1 COMPANY OVERVIEW 148

11.8.2 FINANCIAL OVERVIEW 148

11.8.3 PRODUCTS OFFERED 149

11.8.4 KEY DEVELOPMENTS 149

11.8.5 SWOT ANALYSIS 150

11.8.6 KEY STRATEGIES 150

11.9 SEIKAGAKU CORPORATION 151

11.9.1 COMPANY OVERVIEW 151

11.9.2 FINANCIAL OVERVIEW 152

11.9.3 PRODUCTS OFFERED 153

11.9.4 KEY DEVELOPMENTS 153

11.9.5 SWOT ANALYSIS 154

11.9.6 KEY STRATEGIES 154

11.10 ANIKA THERAPEUTICS 155

11.10.1 COMPANY OVERVIEW 155

11.10.2 FINANCIAL OVERVIEW 156

11.10.3 PRODUCTS/SERVICES OFFERED 157

11.10.4 KEY DEVELOPMENTS 157

11.10.5 SWOT ANALYSIS 158

11.10.6 KEY STRATEGIES 158

12 APPENDIX 159

12.1 REFERENCES 159

12.2 RELATED REPORTS 160

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 19

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 22

TABLE 3 GLOBAL HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 44

TABLE 4 GLOBAL HYALURONIC ACID MARKET FOR COSMETIC GRADE, BY REGION, 2018–2027 (USD MILLION) 45

TABLE 5 GLOBAL HYALURONIC ACID MARKET FOR PHARMACEUTICAL GRADE, BY REGION, 2018–2027 (USD MILLION) 46

TABLE 6 GLOBAL HYALURONIC ACID MARKET FOR FOOD-GRADE, BY REGION, 2018–2027 (USD MILLION) 47

TABLE 7 GLOBAL HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 49

TABLE 8 GLOBAL HYALURONIC ACID MARKET FOR AESTHETICS, BY REGION, 2018–2027 (USD MILLION) 49

TABLE 9 GLOBAL HYALURONIC ACID MARKET FOR OSTEOARTHRITIS, BY REGION, 2018–2027 (USD MILLION) 50

TABLE 10 GLOBAL HYALURONIC ACID MARKET FOR PHARMACEUTICAL API, BY REGION, 2018–2027 (USD MILLION) 51

TABLE 11 GLOBAL HYALURONIC ACID MARKET FOR COSMETICS, BY REGION, 2018–2027 (USD MILLION) 52

TABLE 12 GLOBAL HYALURONIC ACID MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2018–2027 (USD MILLION) 53

TABLE 13 GLOBAL HYALURONIC ACID MARKET FOR OPHTHALMOLOGY, BY REGION, 2018–2027 (USD MILLION) 54

TABLE 14 GLOBAL HYALURONIC ACID MARKET, BY OPHTHALMOLOGY, FOR TYPE, 2018–2027 (USD MILLION) 54

TABLE 15 GLOBAL HYALURONIC ACID MARKET FOR OTHERS, BY REGION, 2018–2027 (USD MILLION) 55

TABLE 16 GLOBAL HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 57

TABLE 17 GLOBAL HYALURONIC ACID MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2018–2027 (USD MILLION) 58

TABLE 18 GLOBAL HYALURONIC ACID MARKET FOR DERMATOLOGY CLINICS & COSMETIC SURGERY CENTERS, BY REGION, 2018–2027 (USD MILLION) 59

TABLE 19 GLOBAL HYALURONIC ACID MARKET FOR FOOD INDUSTRY, BY REGION, 2018–2027 (USD MILLION) 60

TABLE 20 GLOBAL HYALURONIC ACID MARKET FOR PERSONAL CARE, BY REGION, 2018–2027 (USD MILLION) 61

TABLE 21 GLOBAL HYALURONIC ACID MARKET FOR OTHERS, BY REGION, 2018–2027 (USD MILLION) 61

TABLE 22 GLOBAL HYALURONIC ACID MARKET, BY REGION, 2018–2027 (USD MILLION) 64

TABLE 23 NORTH AMERICA: HYALURONIC ACID MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 65

TABLE 24 NORTH AMERICA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 66

TABLE 25 NORTH AMERICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 66

TABLE 26 NORTH AMERICA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 67

TABLE 27 US: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 67

TABLE 28 US: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 68

TABLE 29 US: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 68

TABLE 30 CANADA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 69

TABLE 31 CANADA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 69

TABLE 32 CANADA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 70

TABLE 33 EUROPE: HYALURONIC ACID MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 72

TABLE 34 EUROPE: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 72

TABLE 35 EUROPE: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 73

TABLE 36 EUROPE: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 73

TABLE 37 FRANCE: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 74

TABLE 38 FRANCE: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 74

TABLE 39 FRANCE: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 75

TABLE 40 GERMANY: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 75

TABLE 41 GERMANY: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 76

TABLE 42 GERMANY: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 76

TABLE 43 UK: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 77

TABLE 44 UK: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 77

TABLE 45 UK: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 78

TABLE 46 SPAIN: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 78

TABLE 47 SPAIN: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 79

TABLE 48 SPAIN: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 79

TABLE 49 ITALY: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 80

TABLE 50 ITALY: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 80

TABLE 51 ITALY: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 81

TABLE 52 RUSSIA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 81

TABLE 53 RUSSIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 82

TABLE 54 RUSSIA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 82

TABLE 55 BELGIUM: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 83

TABLE 56 BELGIUM: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 83

TABLE 57 BELGIUM: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 84

TABLE 58 POLAND: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 84

TABLE 59 POLAND: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 85

TABLE 60 POLAND: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 85

TABLE 61 REST OF EUROPE: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 86

TABLE 62 REST OF EUROPE: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 86

TABLE 63 REST OF EUROPE: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 87

TABLE 64 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 89

TABLE 65 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 89

TABLE 66 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 90

TABLE 67 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 90

TABLE 68 CHINA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 91

TABLE 69 CHINA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 91

TABLE 70 CHINA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 92

TABLE 71 JAPAN: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 92

TABLE 72 JAPAN: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 93

TABLE 73 JAPAN: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 93

TABLE 74 INDIA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 94

TABLE 75 INDIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 94

TABLE 76 INDIA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 95

TABLE 77 SOUTH KOREA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 95

TABLE 78 SOUTH KOREA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 96

TABLE 79 SOUTH KOREA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 96

TABLE 80 AUSTRALIA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 97

TABLE 81 AUSTRALIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 97

TABLE 82 AUSTRALIA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 98

TABLE 83 THAILAND: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 98

TABLE 84 THAILAND: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 99

TABLE 85 THAILAND: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 99

TABLE 86 INDONESIA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 100

TABLE 87 INDONESIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 100

TABLE 88 INDONESIA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 101

TABLE 89 REST OF ASIA-PACIFIC: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 101

TABLE 90 REST OF ASIA-PACIFIC: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 102

TABLE 91 REST OF ASIA-PACIFIC: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 102

TABLE 92 LATIN AMERICA: HYALURONIC ACID MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 104

TABLE 93 LATIN AMERICA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 104

TABLE 94 LATIN AMERICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 104

TABLE 95 LATIN AMERICA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 105

TABLE 96 BRAZIL: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 105

TABLE 97 BRAZIL: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 106

TABLE 98 BRAZIL: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 106

TABLE 99 MEXICO: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 107

TABLE 100 MEXICO: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 107

TABLE 101 MEXICO: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 108

TABLE 102 ARGENTINA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 108

TABLE 103 ARGENTINA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 109

TABLE 104 ARGENTINA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 109

TABLE 105 REST OF LATIN AMERICA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 110

TABLE 106 REST OF LATIN AMERICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 110

TABLE 107 REST OF LATIN AMERICA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 111

TABLE 108 MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 113

TABLE 109 MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 113

TABLE 110 MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 114

TABLE 111 MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 114

TABLE 112 SAUDI ARABIA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 115

TABLE 113 SAUDI ARABIA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 115

TABLE 114 SAUDI ARABIA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 116

TABLE 115 UAE: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 116

TABLE 116 UAE: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 117

TABLE 117 UAE: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 117

TABLE 118 TURKEY: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 118

TABLE 119 TURKEY: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 118

TABLE 120 TURKEY: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 119

TABLE 121 SOUTH AFRICA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 119

TABLE 122 SOUTH AFRICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 120

TABLE 123 SOUTH AFRICA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 120

TABLE 124 ISRAEL: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 121

TABLE 125 ISRAEL: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 121

TABLE 126 ISRAEL: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 122

TABLE 127 REST OF THE MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY GRADE, 2018–2027 (USD MILLION) 122

TABLE 128 REST OF THE MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 123

TABLE 129 REST OF THE MIDDLE EAST & AFRICA: HYALURONIC ACID MARKET, BY END USER, 2018–2027 (USD MILLION) 123

TABLE 130 GLOBAL HYALURONIC ACID MARKET: COMPANY RANKING 126

TABLE 131 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL HYALURONIC ACID MARKET 128

TABLE 132 PRODUCT APPROVALS & PRODUCT LAUNCHES 129

TABLE 133 JOINT VENTURES & AGREEMENTS 130

TABLE 134 MARKETING STRATEGY 130

TABLE 135 MERGER & ACQUISITION 130

TABLE 136 ALLERGAN PLC: PRODUCTS/SERVICES OFFERED 133

TABLE 137 ALLERGAN: KEY DEVELOPMENTS 134

TABLE 138 CONTIPRO AS: PRODUCTS OFFERED 136

TABLE 139 CONTIPRO AS: KEY DEVELOPMENTS 137

TABLE 140 SYMATESE: PRODUCTS OFFERED 138

TABLE 141 SYMATESE: KEY DEVELOPMENTS 138

TABLE 142 ZHONGLAN INDUSTRY CO., LTD: PRODUCTS OFFERED 140

TABLE 143 ALTERGON ITALIA SRL: PRODUCTS OFFERED 142

TABLE 144 FIDIA FARMACEUTICI SPA: PRODUCTS OFFERED 144

TABLE 145 FIDIA FARMACEUTICI SPA: KEY DEVELOPMENTS 144

TABLE 146 BIOIBERICA SAU: PRODUCTS OFFERED 146

TABLE 147 BIOIBERICA SAU: KEY DEVELOPMENTS 146

TABLE 148 KEWPIE CORPORATION: PRODUCTS OFFERED 149

TABLE 149 SEIKAGAKU CORPORATION: PRODUCTS OFFERED 153

TABLE 150 SEIKAGAKU CORPORATION: KEY DEVELOPMENTS 153

TABLE 151 ANIKA THERAPEUTICS: PRODUCTS/SERVICES OFFERED 157

TABLE 152 ANIKA THERAPEUTICS: KEY DEVELOPMENTS 157

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 17

FIGURE 2 HYALURONIC ACID MARKET STRUCTURE 18

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 25

FIGURE 4 MARKET DYNAMICS OVERVIEW 28

FIGURE 5 TRADE DATA FOR SKINCARE PRODUCTS (USD MILLION) 29

FIGURE 6 GROWTH OF THE GLOBAL COSMETICS MARKET (%) 30

FIGURE 7 TOP 5 COUNTRIES FOR COSMETIC PROCEDURES, 2019 31

FIGURE 8 DRIVERS IMPACT ANALYSIS 33

FIGURE 9 RESTRAINT IMPACT ANALYSIS 34

FIGURE 10 SUPPLY CHAIN: GLOBAL HYALURONIC ACID MARKET 36

FIGURE 11 PORTER'S FIVE FORCES ANALYSIS: GLOBAL HYALURONIC ACID MARKET 38

FIGURE 12 GLOBAL HYALURONIC ACID MARKET SHARE, BY GRADE, 2020 (%) 43

FIGURE 13 GLOBAL HYALURONIC ACID MARKET, BY GRADE, 2020 & 2027 (USD MILLION) 44

FIGURE 14 GLOBAL HYALURONIC ACID MARKET SHARE, BY APPLICATION, 2020 (%) 48

FIGURE 15 GLOBAL HYALURONIC ACID MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 48

FIGURE 16 GLOBAL HYALURONIC ACID MARKET SHARE, BY END USER, 2020 (%) 56

FIGURE 17 GLOBAL HYALURONIC ACID MARKET, BY END USER, 2020 & 2027 (USD MILLION) 57

FIGURE 18 GLOBAL HYALURONIC ACID MARKET SHARE, BY REGION, 2020 (%) 63

FIGURE 19 GLOBAL HYALURONIC ACID MARKET, BY REGION, 2020 & 2027 (USD MILLION) 64

FIGURE 20 NORTH AMERICA: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 65

FIGURE 21 EUROPE: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 71

FIGURE 22 ASIA-PACIFIC: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 88

FIGURE 23 LATIN AMERICA: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 103

FIGURE 24 MIDDLE EAST &AFRICA: HYALURONIC ACID MARKET, BY COUNTRY, 2020 & 2027 112

FIGURE 25 BENCHMARKING OF MAJOR COMPETITORS 125

FIGURE 26 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL HYALURONIC ACID MARKET 127

FIGURE 27 GLOBAL HYALURONIC ACID MARKET, KEY DEVELOPMENTS & GROWTH STRATEGIES (%) 129

FIGURE 28 SALES, 2020 131

FIGURE 29 R&D EXPENDITURE, 2020 131

FIGURE 30 ALLERGAN PLC: FINANCIAL OVERVIEW SNAPSHOT 133

FIGURE 31 ALLERGAN: SWOT ANALYSIS 134

FIGURE 32 CONTIPRO AS: SWOT ANALYSIS 137

FIGURE 33 SYMATESE: SWOT ANALYSIS 139

FIGURE 34 ZHONGLAN INDUSTRY CO., LTD: SWOT ANALYSIS 141

FIGURE 35 ALTERGON ITALIA SRL: SWOT ANALYSIS 143

FIGURE 36 FIDIA FARMACEUTICI SPA: SWOT ANALYSIS 145

FIGURE 37 BIOIBERICA SAU: SWOT ANALYSIS 147

FIGURE 38 KEWPIE CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 148

FIGURE 39 KEWPIE CORPORATION: SWOT ANALYSIS 150

FIGURE 40 SEIKAGAKU CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 152

FIGURE 41 SEIKAGAKU CORPORATION: SWOT ANALYSIS 154

FIGURE 42 ANIKA THERAPEUTICS INC.: FINANCIAL OVERVIEW SNAPSHOT 156

FIGURE 43 ANIKA THERAPEUTICS INC.: SWOT ANALYSIS 158

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.